California SJS Lawsuits: Hold Drugmakers Accountable
TL;DR: If you developed SJS/TEN after taking a medication, California law may allow claims against responsible parties. Prescription drug cases often focus on whether warnings were adequate and whether those warnings reached your prescriber under the learned intermediary doctrine. Claims against generic manufacturers are frequently limited by federal preemption. Strict filing deadlines may apply—talk to a California attorney promptly. Contact us for a free consultation.
What Are SJS and TEN?
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe adverse reactions often triggered by medications. They can cause widespread skin detachment, painful blisters, eye and mucous membrane damage, infections, and long-term complications. Treatment typically requires hospitalization, sometimes in burn units, and recovery can involve significant medical costs and lasting impacts on vision, scarring, and quality of life.
Who Can Be Held Responsible in California?
Depending on the facts, potential defendants may include brand-name or generic drug manufacturers, distributors and others in the chain of commerce, and in some cases healthcare providers or pharmacies. California product liability focuses on whether a product was defective and whether inadequate warnings or instructions failed to reasonably inform foreseeable users of significant risks. For prescription drugs specifically, California generally bars strict liability design-defect claims under comment k; warning-based and negligence theories are the typical paths forward. See Brown v. Superior Court, 44 Cal.3d 1049 (1988). Pharmacies are generally not strictly liable for dispensing prescription drugs. See Murphy v. E.R. Squibb & Sons, Inc., 40 Cal.3d 672 (1985).
Failure-to-Warn Claims and the Learned Intermediary Doctrine
In prescription drug cases, California applies the learned intermediary doctrine: manufacturers must provide adequate warnings to prescribers, who then advise patients. If a label failed to adequately warn about SJS/TEN risks or early symptoms, and that failure was a substantial factor in causing injury, a warning-defect claim may be viable. See Carlin v. Superior Court, 13 Cal.4th 1104 (1996). Relevant evidence may include FDA-approved labeling, safety communications, medical literature, and prescribing records. See FDA Medication Guides and safety information: FDA Drug Safety.
Brand-Name vs. Generic Drugs
Warning-based claims against brand-name manufacturers may proceed under California law when supported by evidence of inadequate labeling or communications. California also recognizes innovator liability in certain circumstances, allowing negligence-based warning claims against the brand-name manufacturer even if the patient ingested a generic version. See T.H. v. Novartis Pharm. Corp., 4 Cal.5th 145 (2017). By contrast, federal preemption can bar many state-law failure-to-warn and design-defect claims against generic manufacturers. See PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011) and Mutual Pharm. Co. v. Bartlett, 570 U.S. 472 (2013).
Key Evidence to Preserve
- The medication name, dose, lot number, and manufacturer (keep the bottle/packaging).
- Pharmacy printouts and Medication Guides.
- Hospital and dermatopathology records, including biopsy results.
- Photos of the rash and mucosal involvement.
- A timeline of when you started/stopped the drug and when symptoms began.
- Witness statements from family or caregivers.
- Employment and insurance records showing lost wages and expenses.
Practical Tip
Request and save the FDA Medication Guide that comes with your prescription. You can also find it online at FDA Medication Guides. Bring these documents to medical appointments.
SJS/TEN Action Checklist
- Seek emergency care; bring all medications and packaging.
- Ask providers to document suspected SJS/TEN and likely triggers.
- Do not restart the suspected drug unless instructed by your physicians.
- Photograph rashes, eyes, and mouth involvement daily.
- Secure pharmacy records and prescribing notes.
- Track missed work, out-of-pocket costs, and caregiver time.
- Speak with a California pharmaceutical injury attorney promptly.
Damages You May Recover
- Medical expenses (past and future).
- Lost income and diminished earning capacity.
- Pain and suffering, disfigurement, and loss of consortium.
- Punitive damages in egregious cases, if proven by clear and convincing evidence of malice, oppression, or fraud. See Cal. Civ. Code § 3294.
How Statutes of Limitations Work
Strict filing deadlines apply and can vary based on claim type, discovery of the injury and its cause, and who is being sued. Many California personal injury/product liability claims must be filed within two years. See Cal. Code Civ. Proc. § 335.1. If a healthcare provider is a defendant, special rules and shorter timeframes may apply (generally one year from discovery and no more than three years from the date of injury, subject to exceptions). See Cal. Code Civ. Proc. § 340.5. Missing a deadline can end your claim—consult counsel promptly.
How We Investigate SJS Cases
We review medical records, pathology, and medication history; consult dermatology, ophthalmology, and pharmacovigilance experts; analyze label histories and FDA safety data; and pursue evidence from manufacturers and pharmacies. We build a clear causation timeline and evaluate liability against appropriate defendants.
No Upfront Fees
We handle SJS/TEN cases on a contingency basis. You pay no attorney’s fees unless we recover compensation for you.
FAQs
Do I have a case if I took a generic drug?
Possibly. Many claims against generics are preempted, but negligence-based claims may exist against the brand-name innovator in limited circumstances. An attorney can evaluate options under T.H. v. Novartis.
How soon should I contact a lawyer?
As soon as possible. Evidence can disappear quickly and California limitation periods can be short, especially if a healthcare provider is involved.
What if my doctor never warned me?
Under the learned intermediary doctrine, the key question is whether the manufacturer adequately warned your prescriber. Label adequacy and causation are central issues.
What compensation is available?
Medical costs, lost earnings, pain and suffering, and potentially punitive damages in qualifying cases.
Free, Confidential Consultation
If you or a loved one developed SJS or TEN after taking a medication, we can assess your potential claims under California law and explain your options. Contact us.
Disclaimer (California): This blog post is for general informational purposes only and is not legal advice. Reading it does not create an attorney-client relationship. Legal outcomes and deadlines depend on specific facts and applicable California law. Consult a licensed California attorney about your situation.